RENGA, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 5.042
AS - Asia 2.821
EU - Europa 2.743
SA - Sud America 473
Continente sconosciuto - Info sul continente non disponibili 184
AF - Africa 75
OC - Oceania 3
Totale 11.341
Nazione #
US - Stati Uniti d'America 4.807
SG - Singapore 1.366
IE - Irlanda 487
CN - Cina 414
IT - Italia 406
UA - Ucraina 381
RU - Federazione Russa 378
BR - Brasile 364
HK - Hong Kong 362
SE - Svezia 267
VN - Vietnam 249
FR - Francia 194
FI - Finlandia 156
DE - Germania 155
CA - Canada 107
GB - Regno Unito 105
TR - Turchia 75
IN - India 73
KR - Corea 63
EE - Estonia 40
AR - Argentina 34
PL - Polonia 34
BD - Bangladesh 33
MX - Messico 33
CO - Colombia 23
CH - Svizzera 22
PH - Filippine 22
ZA - Sudafrica 21
ES - Italia 20
IQ - Iraq 20
JP - Giappone 20
CR - Costa Rica 19
CZ - Repubblica Ceca 19
NL - Olanda 19
EC - Ecuador 17
PK - Pakistan 16
VE - Venezuela 15
BE - Belgio 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
GT - Guatemala 13
HN - Honduras 13
RO - Romania 13
AT - Austria 12
ID - Indonesia 12
IL - Israele 12
SV - El Salvador 10
SC - Seychelles 9
TT - Trinidad e Tobago 9
CL - Cile 8
GR - Grecia 8
ET - Etiopia 7
JM - Giamaica 7
LB - Libano 7
NI - Nicaragua 7
AE - Emirati Arabi Uniti 6
CW - ???statistics.table.value.countryCode.CW??? 6
KE - Kenya 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
EG - Egitto 5
GP - Guadalupe 5
KZ - Kazakistan 5
JO - Giordania 4
PA - Panama 4
PE - Perù 4
PR - Porto Rico 4
TN - Tunisia 4
AU - Australia 3
KG - Kirghizistan 3
LT - Lituania 3
NP - Nepal 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
AO - Angola 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
LY - Libia 2
NG - Nigeria 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
Totale 11.154
Città #
Singapore 997
San Jose 568
Chandler 552
Dublin 486
Ashburn 457
Hong Kong 362
San Mateo 254
Santa Clara 181
Jacksonville 170
Boardman 160
Dong Ket 156
Council Bluffs 155
Altamura 140
Medford 119
Princeton 119
Beijing 116
Moscow 116
Lauterbourg 103
Lawrence 102
Andover 98
Wilmington 98
Ann Arbor 86
Perugia 60
New York 58
Seoul 51
Los Angeles 50
São Paulo 48
Izmir 45
Des Moines 43
Columbus 42
The Dalles 40
Saint Petersburg 37
Helsinki 31
Ho Chi Minh City 29
North Bergen 27
Dallas 25
Munich 25
Orem 25
Phoenix 23
Chennai 22
Rio de Janeiro 21
Toronto 20
Warsaw 20
Chicago 19
Montreal 19
Piscataway 19
Tokyo 19
London 17
Naples 17
Boston 16
Falls Church 16
Hanoi 16
Norwalk 16
San José 15
Brooklyn 14
Denver 14
Milan 14
Rome 14
Atlanta 13
Brussels 13
Dearborn 13
Houston 13
San Paolo di Civitate 13
Shanghai 13
Stockholm 13
Timisoara 13
Woodbridge 13
Olomouc 12
Ottawa 12
Mexico City 11
Quito 11
Turku 11
Buffalo 10
Frankfurt am Main 10
Nuremberg 10
Tashkent 10
Belo Horizonte 9
Guatemala City 9
Johannesburg 9
San Salvador 9
Baghdad 8
Campinas 8
Manchester 8
New Delhi 8
Queens 8
Salvador 8
Addis Ababa 7
Ankara 7
Bogotá 7
Jakarta 7
Managua 7
Philadelphia 7
Poplar 7
San Francisco 7
Turin 7
Amsterdam 6
Auburn Hills 6
Calgary 6
Charlotte 6
Curitiba 6
Totale 6.973
Nome #
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 162
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 152
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 152
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 150
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 146
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 146
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 143
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 143
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 139
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 137
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 136
Antiatherosclerotic effect of farnesoid X receptor. 133
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 129
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 129
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 128
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 125
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 124
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 122
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 121
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 121
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 120
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 120
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 118
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 118
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 117
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 116
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 116
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 116
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 116
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 115
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 113
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 109
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 107
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 107
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 106
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 105
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 104
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 104
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 103
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 102
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 102
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 102
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 101
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 101
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 101
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 100
Il valore predittivo del polimorfismo C1237-T di TLR9 mutato nell’eruzione eritemato-papulo-pustolosa da inibitori dei recettori del fattore di crescita epidermico 100
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 100
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 99
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 98
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 97
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. 97
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 96
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 96
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 96
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 94
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 94
Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist 94
The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. 92
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 92
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 91
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 90
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 90
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 89
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 89
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 88
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 87
The methyl trasnferase PRMT1 functions as coactivator of FXR/RXR and regulates transcription of FXR responsive genein hepatocytes 87
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 87
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 85
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 85
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 84
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 83
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 82
The bile acid receptor FXR is a modulator of intestinal innate immunity. 82
Nitric oxide (NO)-releasing naproxen (HCT-3012) interactions with aspirin in gastric mucosa of arthritic rats reveals a role for aspirin-triggered lipoxin, prostaglandins and NO in gastric protection. 81
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 81
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 81
Quantitative NMR-Derived Interproton Distances Combined with QuantumMechanical Calculations of (13)C Chemical Shifts in the StereochemicalDetermination of Conicasterol F, a Nuclear Receptor Ligand from Theonellaswinhoei. 81
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 79
The Nuclear Receptor SHP Mediates Inhibition of Hepatic Stellate Cells by FXR and Protects Against Liver Fibrosis 79
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 79
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 78
The Bile Acid Sensor FXR Induces the Glucocorticoid Receptor in the Liver in a Promoter-Dependent Manner 78
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 78
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 77
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 77
Polyhydroxylated sterols from the Indonesian softcoral Sinularia sp. and their effect on farnesoid X-activated receptor. 76
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 76
Isoswinholide B and swinholide K, potently cytotoxic dimeric macrolides from Theonella swinhoei. 74
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-related Diseases. 74
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 74
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 72
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 72
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 71
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 71
Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor gamma 71
The bile acid sensor FXR regulates insulin transcription and secretion. 71
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 71
The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo 70
Totale 10.113
Categoria #
all - tutte 52.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022660 0 0 0 0 31 10 10 342 6 13 92 156
2022/20231.798 129 344 11 175 135 188 0 89 662 2 47 16
2023/2024600 42 78 46 6 4 4 140 26 36 20 126 72
2024/20251.651 17 144 61 46 250 56 34 111 336 106 280 210
2025/20263.418 245 193 236 346 431 302 652 192 426 273 78 44
2026/20271.270 75 94 265 746 90 0 0 0 0 0 0 0
Totale 11.341